| Mary Melissa Albritton, MD | |
|
2449 Hospital Dr, Suite 400, Bossier City, LA 71111-2399 | |
| (318) 212-7902 | |
| (318) 212-7905 |
| Full Name | Mary Melissa Albritton |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 21 Years |
| Location | 2449 Hospital Dr, Bossier City, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275744112 | NPI | - | NPPES |
| 1059650 | Medicaid | LA | |
| 4P323 | Other | LA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD.200148 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
| Christus Health Shreveport - Bossier | Shreveport, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wk Endocrine Specialists | 6406980689 | 8 |
News Archive
In a paper recently published in Pathogens, in silico affinity studies by researchers at the University of Illinois, USA, reveal several potential peptide binding sites required for HS-spike protein and ACE2-spike protein bond formation, and synthesis of suitable peptide inhibitors reveals impaired SARS-CoV-2 cell entry.
EKF Diagnostics, the global diagnostics company, announces that it will be highlighting the robustness of its new DiaSpect Tm POC hemoglobin analyzer.
In a world-first discovery, scientists at Sydney's Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.
Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.
› Verified 9 days ago
| Entity Name | Wk Endocrine Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073831004 PECOS PAC ID: 6406980689 Enrollment ID: O20100811000036 |
News Archive
In a paper recently published in Pathogens, in silico affinity studies by researchers at the University of Illinois, USA, reveal several potential peptide binding sites required for HS-spike protein and ACE2-spike protein bond formation, and synthesis of suitable peptide inhibitors reveals impaired SARS-CoV-2 cell entry.
EKF Diagnostics, the global diagnostics company, announces that it will be highlighting the robustness of its new DiaSpect Tm POC hemoglobin analyzer.
In a world-first discovery, scientists at Sydney's Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.
Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Melissa Albritton, MD 2449 Hospital Dr, Bossier City, LA 71111-2399 Ph: (318) 212-7902 | Mary Melissa Albritton, MD 2449 Hospital Dr, Suite 400, Bossier City, LA 71111-2399 Ph: (318) 212-7902 |
News Archive
In a paper recently published in Pathogens, in silico affinity studies by researchers at the University of Illinois, USA, reveal several potential peptide binding sites required for HS-spike protein and ACE2-spike protein bond formation, and synthesis of suitable peptide inhibitors reveals impaired SARS-CoV-2 cell entry.
EKF Diagnostics, the global diagnostics company, announces that it will be highlighting the robustness of its new DiaSpect Tm POC hemoglobin analyzer.
In a world-first discovery, scientists at Sydney's Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.
Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.
› Verified 9 days ago
Neelima Chintapalli, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2539 Viking Dr, Bossier City, LA 71111 Phone: 318-848-2970 Fax: 318-848-2971 | |
Diana Magpayo Lim, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2400 Hospital Dr, Suite 420, Bossier City, LA 71111 Phone: 318-212-7910 Fax: 318-212-7915 | |
Dr. Barry Marvin Osherowitz, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1608 Jimmie Davis Hwy, Bossier City, LA 71112 Phone: 318-747-2510 Fax: 318-742-3727 | |
Nealan Dewayne Prather, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2400 Hospital Dr, Suite 420, Bossier City, LA 71111 Phone: 318-212-7910 Fax: 318-212-7915 | |
Leslie Jean Sewell, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2300 Hospital Dr, Suite 320, Bossier City, LA 71111 Phone: 318-212-7848 Fax: 318-212-7855 | |
Tom Chalermchai Rodsuwan, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2400 Hospital Dr, Suite 130, Bossier City, LA 71111 Phone: 318-212-7990 Fax: 318-212-7995 | |
Charles Alfred Powers, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2400 Hospital Dr, Suite 420, Bossier City, LA 71111 Phone: 318-212-7910 Fax: 318-212-7915 |